NO962752D0 - Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose - Google Patents

Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose

Info

Publication number
NO962752D0
NO962752D0 NO962752A NO962752A NO962752D0 NO 962752 D0 NO962752 D0 NO 962752D0 NO 962752 A NO962752 A NO 962752A NO 962752 A NO962752 A NO 962752A NO 962752 D0 NO962752 D0 NO 962752D0
Authority
NO
Norway
Prior art keywords
diaryl
osteoporosis
medicament
prevention
manufacture
Prior art date
Application number
NO962752A
Other languages
English (en)
Other versions
NO962752L (no
Inventor
Virender M Labroo
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO962752D0 publication Critical patent/NO962752D0/no
Publication of NO962752L publication Critical patent/NO962752L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO962752A 1993-12-30 1996-06-28 Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose NO962752L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/175,899 US5389646A (en) 1993-12-30 1993-12-30 Methods for treatment and prevention of bone loss using 2,3-benzopyrans
PCT/US1994/014568 WO1995017892A1 (en) 1993-12-30 1994-12-14 Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis

Publications (2)

Publication Number Publication Date
NO962752D0 true NO962752D0 (no) 1996-06-28
NO962752L NO962752L (no) 1996-08-29

Family

ID=22642125

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962752A NO962752L (no) 1993-12-30 1996-06-28 Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose

Country Status (11)

Country Link
US (1) US5389646A (no)
KR (1) KR100213963B1 (no)
CN (1) CN1142767A (no)
AU (1) AU701411B2 (no)
CA (1) CA2180178C (no)
CZ (1) CZ192396A3 (no)
FI (1) FI962685A (no)
HU (1) HUT75705A (no)
NO (1) NO962752L (no)
RU (1) RU2166316C2 (no)
WO (1) WO1995017892A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US5637598A (en) * 1994-11-18 1997-06-10 Eli Lilly And Company Methods of inhibiting bone loss
PL330814A1 (en) 1996-06-20 1999-06-07 Regents Board Of Compounds for and methods of delivering pharmaceutical preparations and their application
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
KR101698238B1 (ko) 2010-06-10 2017-01-19 세라곤 파마슈티컬스, 인크. 에스트로겐 수용체 조정제 및 이의 용도
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
SG11201403002RA (en) 2011-12-14 2014-07-30 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof
PL3253208T3 (pl) 2015-02-02 2021-11-08 Mei Pharma, Inc. Terapie kombinowane do zastosowania w leczeniu nowotworu piersi
CN104926776B (zh) * 2015-07-06 2018-05-25 江南大学 4-苯甲酰亚甲基黄烷类衍生物的绿色合成方法
IL283559B (en) * 2015-10-27 2022-07-01 Sun Pharma Advanced Res Co Ltd New heterocyclic anti-estrogens
KR20220046586A (ko) 2019-07-22 2022-04-14 썬 파마 어드밴스트 리서치 컴패니 리미티드 선택적 에스트로겐 수용체 분해제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US4210644A (en) * 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US4489056A (en) * 1982-06-30 1984-12-18 Merck & Co., Inc. Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
US4644012A (en) * 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
JPS60132976A (ja) * 1983-12-21 1985-07-16 Takeda Chem Ind Ltd 新規３−フエニル−４ｈ−１−ベンゾピラン−４−オン誘導体
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
JP3502403B2 (ja) * 1991-12-16 2004-03-02 アベンティス ファーマ株式会社 骨吸収抑制剤
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
FI962685A0 (fi) 1996-06-28
AU701411B2 (en) 1999-01-28
CA2180178A1 (en) 1995-07-06
AU1403995A (en) 1995-07-17
CN1142767A (zh) 1997-02-12
CZ192396A3 (en) 1997-03-12
HU9601786D0 (en) 1996-09-30
WO1995017892A1 (en) 1995-07-06
US5389646A (en) 1995-02-14
CA2180178C (en) 2001-03-20
NO962752L (no) 1996-08-29
RU2166316C2 (ru) 2001-05-10
KR100213963B1 (en) 1999-08-02
FI962685A (fi) 1996-08-28
HUT75705A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
HK1011926A1 (en) The use of bisphosphonates in bone surgery
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
GB9415125D0 (en) Surgical product and its use
GB9419974D0 (en) Modular orthopedic brace
GB2277826B (en) Surgical and/or clinical apparatus
HK1092380A1 (en) Use of plant extract in the manufacture of a medicament for treating diseases of increase bone resorption and composition thereof
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
NO972426D0 (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
GB9213008D0 (en) Knee surgery
EP0703780A4 (en) USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
NO961226D0 (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
EP0744176A3 (en) Methods for inhibiting bone loss
GB9303200D0 (en) Orthopaedic casting bandage
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
ZA96830B (en) Orthopaedic casting and splinting materials
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
GB9217124D0 (en) Medical treatment
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
GB9420188D0 (en) Bone fixator
GB9321793D0 (en) Medical treatment
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
NO933549D0 (no) Vippeanordning for rullestol ved behandling av en pasient
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
GB9314075D0 (en) Orthopaedic splinting materials

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application